Articles
Page 18 of 22
-
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P80
-
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P76 -
The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P75 -
Endothelial GC-A can be a therapeutic target for metabolic syndrome
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P73 -
Receptor guanylyl cyclase B-mediated cGMP signalling controls axon bifurcation of cranial sensory ganglion neurons at the embryonic hindbrain
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P71 -
Differential regulation of platelet inhibition by cGMP- and cAMP-dependent protein kinases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P69 -
Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P68 -
Krait natriuretic peptide (KNP): a non-classical NP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P67 -
Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P65 -
Function of cGMP-dependent protein kinase II in volume expansion-induced diuresis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P63 -
Fishing for elusive cCMP-degrading phosphodiesterases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P62 -
In striatum phosphodiesterase 10A is part of a synaptic signalling complex
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P59 -
Potent inhibition of nitroglycerin bioactivation by diphenyleneiodonium (DIP)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P49 -
Video microscopy as a tool to visualize cGMP effects on contractility and sperm transport in seminiferous tubules and the epididymal duct
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P44 -
Alternative splicing of α1 and β1 sGC genes is altered in aortic disease
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P42 -
Evidence for functional coupling of cGMP/cGKI signalling and TRPC channels in endothelium but not in vascular smooth muscle
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P40 -
Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O38 -
A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P38 -
Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P36 -
Interstitial cells of Cajal plasticity rather than regeneration restores slow-wave activity and enteric neurotransmission upon acute damage
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P34 -
A novel physiological significance of natriuretic peptides in cancer metastasis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O34 -
NO-H2S interactions involve cGMP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O32 -
Phosphodiesterase 5 is main regulator of brown adipocyte differentiation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P32 -
Cyclic GMP-mediated intercellular communication in mammalian ovarian follicles
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P31 -
Interstitial cells of Cajal link excitatory and nitrergic inhibitory neurotransmission with slow-wave activity in the intestine
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O30 -
Chronic activation of heme free soluble guanylate cyclase leads to cardio-renal protection in experimental hypertension
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P30 -
GUCY2C at the intersection of obesity and colorectal cancer
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O28 -
The role of VASP in cGMP-mediated vascular smooth muscle relaxation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P28 -
Non-genomic thyroid hormone signaling through NO/cGMP/PKGII
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O26 -
PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P26 -
Natriuretic peptides and fat metabolism
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O24 -
Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P23 -
Chronic beta-adrenergic blockade prevents volume overload-induced re-localization and oxidation of soluble guanylyl cyclase
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O22 -
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P22 -
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P21 -
Mechanisms driving heme insertion into apo-sGC during its maturation in cells
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O18 -
Structures of human PKG reveal cGMP-selectived activation mechanisms
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O16 -
Soluble guanylate cyclase crystal clear: 1stcrystal structure of the wild-type human heterodimeric sGC catalytic domains and implications for activity
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O14 -
Receptor guanylyl cyclase-G is a novel thermosensor in Grueneberg ganglion neurons involved in coolness-induced ultrasonic distress calls in mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P14 -
Identification and quantitation of 2´,3´-cGMP in murine tissues
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P12 -
G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P11 -
Pulmonary vascular adaptation to high-altitude living
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O9 -
Genetic variants of ANP and cardiometabolic protection: from populations to novel therapeutics
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O7 -
Effects of omeprazole and AlOH/MgOH on riociguat absorption
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P6 -
Pharmacokinetic interaction of ketoconazole, clarithromycin, and midazolam with riociguat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P5 -
What have genome-wide association studies taught us about cGMP and blood pressure regulation?
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O5 -
Effect of nitrite treatment on endothelial nitric oxide synthase in human left ventricle biopsy
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P3 -
Hydroxyurea reduces leukocyte interactions with the vessel wall in a haemolytic mouse model via a possible NO/cGMP-mediated effect
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P2 -
Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O2 -
Neutral endopeptidase inhibitors SOL-1 and candoxatril counteract kidney fibrosis by reducing myofibroblast formation in mouse UUO model
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P1
Annual Journal Metrics
-
Citation Impact
2.605 - 2-year Impact Factor (2021)
2.943 - 5-year Impact Factor (2021)
0.953 - SNIP (Source Normalized Impact per Paper)
0.497 - SJR (SCImago Journal Rank)Speed
42 days to first decision for all manuscripts (Median)
172 days to first decision for reviewed manuscripts only (Median)Usage
588,461 Downloads (2021)
402 Altmetric mentions (2021)
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication